FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Phenylephrine Hydrochloride | 40 mg/260 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Rocuronium Bromide | 50 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Succinylcholine Chloride | 100 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Succinylcholine Chloride | 200 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Vancomycin Hydrochloride | 1.5 g/515 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Vancomycin Hydrochloride | 2 g/520 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Vancomycin Hydrochloride | 1.25 g/262.5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Vancomycin Hydrochloride | 1.5 g/265 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Vancomycin Hydrochloride | 1.75 g/517.5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Vancomycin Hydrochloride | 750 mg/257.5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Vancomycin Hydrochloride | 1 g/260 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Diltiazem Hydrochloride | 125 mg/125 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Ephedrine Sulfate | 50 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Ephedrine Sulfate | 25 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Glycopyrrolate | .4 mg/2 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Glycopyrrolate | .6 mg/3 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Ketamine | 20 mg/2 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Ketamine Hydrochloride | 50 mg/5 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| New England Life Care LLC dba Advanced Compounding Solutions | 827490728 | Lidocaine Hydrochloride | 100 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Lidocaine; Tetracaine | .2 g/20 g; .2 g/20 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Lidocaine; Tetracaine | 4.6 g/20 g; 1.4 g/20 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Lidocaine; Tetracaine | 4.6 g/20 g; 1.4 g/20 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Ascorbic Acid; Tretinoin; Hyaluronic Acid | .4 g/20 g; .01 g/20 g; .04 g/20 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Aspartic Acid; Arginine | .9 g/90 g; 1.8 g/90 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate | 100 mg/1 mL; 30 mg/1 mL; 2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate | .2 mg/1 mL; 18 mg/1 mL; 2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate | .2 mg/1 mL; 18 mg/1 mL; 2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Naltrexone Hydrochloride | .0045 g/.25 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Naltrexone Hydrochloride | .003 g/.25 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Naltrexone Hydrochloride | .0015 g/.25 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | .01 mg/1 mL; .9 mg/1 mL; .1 mg/1 mL; .002 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | .1 mg/1 mL; 9 mg/1 mL; 1 mg/1 mL; .01 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | .1 mg/1 mL; 9 mg/1 mL; 1 mg/1 mL; .01 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Azithromycin Dihydrate | .2612 g/.42 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; .2 mg/1 mL; 8 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Phenylephrine Hydrochloride; Lidocaine Hydrochloride; Prilocaine Hydrochloride | .15 g/30 g; 6.9 g/30 g; 3 g/30 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Polidocanol | .007 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Polidocanol | .03 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Polidocanol | .02 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Prilocaine Hydrochloride; Cyclobenzaprine Hydrochloride; Baclofen; Lidocaine Hydrochloride; Ketoprofen | .5 g/20 g; .4 g/20 g; .4 g/20 g; .5 g/20 g; 2 g/20 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Prilocaine Hydrochloride; Lidocaine | 4.2 g/30 g; 4.2 g/30 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Progesterone | .05 g/.27 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Progesterone | .025 g/.27 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Sermorelin Acetate | .0005 g/.25 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Sulfamethoxazole; Amphotericin B; Chloramphenicol | .05 g/.105 g; .005 g/.105 g; .05 g/.105 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Terbutaline | .003 g/.17 g | 2021-2 | source_no_ndc | 2026-11-12 |